Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01532206 · ClinicalTrials.gov registry record · NA
IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01532206: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT01532206 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01532206, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Remote ischemic preconditioning has proven beneficial in patients undergoing percutaneous coronary intervention and coronary artery bypass surgery. Animal studies suggest remote ischemic preconditioning increases levels of interleukin 10. The investigators aim to determine whether remote ischemic preconditioning results in an increase in IL-10 levels in patients following acute myocardial infarction.
Interventions
- OTHER Blood pressure cuff insufflation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01532206
The ClinicalTrials.gov registry entry for NCT01532206 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood pressure cuff insufflation is the first listed.
NCT01532206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01532206 about?
NCT01532206 is a clinical study titled "IL-10 Levels and Remote Ischemic Preconditioning in Acute Myocardial Infarction". Remote ischemic preconditioning has proven beneficial in patients undergoing percutaneous coronary intervention and coronary artery bypass surgery. Animal studies suggest remote ischemic preconditioning increases levels of interleukin 10. The investigators aim to determine whether remote ischemic pr...
What is the current status of trial NCT01532206?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2013-03. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01532206?
The interventions under investigation include: Blood pressure cuff insufflation (OTHER).
Who is sponsoring clinical trial NCT01532206?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.